Share-based Payments Share-based payments are included in research and development and general and administrative rather than being presented separately in the statements of comprehensive income. During the three and six months ended June 30, 2023, we recognized share-based payments of $0.5 million and $0.9 million, respectively (2022 – $0.6 million and $1.7 million, respectively). The expense recognized in a given period reflects the fair value of 9 past and newly-granted stock options outstanding during the period and is impacted by factors such as vesting and fluctuations in share price. Share-based payments are a non-cash expense which does not impact operating cash flows. During the six months ended June 30, 2023, we granted 2,000,000 stock options with a weighted-average exercise price of CAD$0.10 and a weighted-average fair value of $0.05 per option (2022 – 740,000 stock options with a weighted-average exercise price of CAD$0.58 and a weighted-average fair value of $0.24 per option), and we granted 6,991,840 restricted stock units (2022 – 2,887,700 restricted stock units).

Disgusting!  I feel violated!